Related Experiment Video
Updated: Mar 16, 2026
13:34
Assessment of Memory Function in Pilocarpine-induced Epileptic Mice
Published on: June 4, 2020
9.0K
Effect of Seizures on the Developing Brain and Cognition
1Department of Neurological Sciences, University of Vermont College of Medicine, Burlington, VT.
Seminars in Pediatric Neurology
|August 22, 2016
Summary
Early-life seizures in epilepsy can lead to cognitive impairment by altering brain development, even without cell loss. Understanding these neurobiological changes offers potential therapeutic targets for epilepsy-associated cognitive deficits.
Area of Science:
- Neuroscience
- Epilepsy Research
- Cognitive Science
Background:
- Epilepsy is a complex neurological disorder with significant comorbidities.
- Cognitive impairment is a common and distressing comorbidity in epilepsy patients.
- Refractory seizures, especially early in life, adversely affect cognitive function.
Purpose of the Study:
- To explore the neurobiological mechanisms underlying cognitive impairment in early-life epilepsy.
- To investigate how seizures impact brain development and cognitive skills.
Main Methods:
- Utilized rodent models to study the effects of early-life seizures.
- Examined neurogenesis, synaptogenesis, and network alterations post-seizure.
Main Results:
- Early-life seizures in rodents do not cause cell loss but induce changes in neurogenesis and synaptogenesis.
- Seizures alter excitatory/inhibitory balance, network connectivity, and temporal coding.
- These neurobiological changes correlate with impaired cognitive skills.
Conclusions:
- Early-life seizures induce specific neurobiological alterations that underpin cognitive deficits in epilepsy.
- This enhanced understanding provides a basis for developing novel therapeutic interventions for seizure-induced cognitive impairment.
Related Concept Videos
01:24Epilepsy and Seizures: Overview
1.6K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.6K
01:13Seizures: Classification
2.0K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
2.0K
01:27Language and Cognition
929
Language serves as a bridge between ideas and communication, influencing how individuals perceive and interact with the world. Psychologists have long debated whether language shapes thought or vice versa. This discussion gained grip with Edward Sapir and Benjamin Lee Whorf in the 1940s, who proposed that language determines thought, a concept known as linguistic determinism. They suggested that the vocabulary and structure of a language influence how its speakers think and perceive reality.
929
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
1.1K
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.1K
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
1.6K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.6K
01:20Antiepileptic Drugs: Potassium Channel Activators
895
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
895